A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
| 178.2 | D-Ala2, N-MePhe4, Gly5-ol-enkephalin (DAMGO), a mu-opioid receptor agonist, | |
| 153.8 | r subtypes in regulation of behavioural sensitization induced by | D-amphetamine |
| 075.7 | Role of calcineurin in locomotor and rewarding effects of | d-amphetamine and morphine: study in transgenic mice |
| 153.19 | medial prefrontal cortex during long-term self-administration of | d-amphetamine by rats |
| 018.10 | e brain and peripheral nervous system and it enhances L-dopa and | D-amphetamine effects in an animal model of Parkinson's disease |
| 057.6 | Inhibition of 5-hydroxytryptamine synthesis increases | d-amphetamine evoked release of noradrenaline in the frontal cortex and the |
| 175.25 | Effects of | d-amphetamine on the peak procedure |
| 153.2 | The GABA-B agonist baclofen attenuates | d-amphetamine self-administration in the rat |
| 153.10 | Spontaneous novelty seeking and | d-amphetamine-induced conditioning and sensitization in adult mice: evidenc |
| 085.3 | D-serine prevents age-related alterations of NMDA receptor activation in CA | |
| 081.7 | Direct measurement of | D-serine release from cultured astrocytes and brain slices |
| 175.15 | Improvement in object recognition memory by a dopamine | D1 agonist is associated with changes in P-CREB level within the rat prefro |
| 153.4 | Involvement of | D1 and D2 dopaminergic receptors in cocaine-seeking behaviour reinstatement |
| 180.2 | Localization of | D1 and D2 receptors and dopamine receptor interacting proteins in the prefr |
| 012.22 | Presence of dopamine | D1 and D2 receptors subtypes in the mammal ependyma |
| 155.2 | Interactions between A1 adenosine, | D1 dopamine and mGluR5 receptors in the reserpine-treated rat model of Park |
| 155.16 | Role of | D1 dopamine receptor (DAR) in controlling the flow of cortical activity thr |
| 012.9 | D1 Dopaminergic receptor mRNA level in the rat striatum after chronic treat | |
| 056.4 | Selective stimulation of striatal | D1 or D2 dopamine receptors causes opposite changes on fos expression in th |
| 014.8 | Phospholipase | D1 plays essential role in neurotransmitter exocytosis by controlling the f |
| 012.5 | SKF 38393, dopamine | D1 receptor agonist, induces c-Fos in the CRF- but not vasopressin-containi |
| 175.16 | Microinjection of a | D1 receptor antagonist into the prefrontal cortex disrupts spatial learning |
| 012.20 | Dopamine | D1 receptor in thalamocortical projection systems of the macaque monkey |
| 186.4 | Dopamine | D1 receptor subtype stimulation is required for the induction of dyskinesia |
| 012.16 | Receptor recycling mediates plasma membrane recovery of dopamine | D1 receptors in dendrites and axons after agonist-induced endocytosis in pr |
| 081.20 | Activation of | d1-like dopamine receptors enhances burst firing in rat subthalamic nucleus |
| 016.8 | Endogenous dopamine amplifies ischemic LTP via | D1-like receptors |
| 119.17 | -induced oscillatory network activity in rat hippocampal CA3 via | D1-like receptors |
| 062.2 | Calcyon and the mechanism of | D1/D5 dopamine receptor dual effector coupling |
| 012.23 | D4 and | D1/D5 dopamine receptors interact synergistically on c-Fos expression in th |
| 107.20 | Blockade of dopamine | D1/D5 receptors causes a delay-dependent impairment of spatial memory in a |
| 107.17 | Impairment on object recognition memory in dopamine | D1A receptor knockout mice |
| 213.11 | ned treatment with imipramine and amantadine on central dopamine | D2 and D3 receptors in rats |
| 012.15 | Expression of dopamine receptor | D2 and D4 subtypes during postnatal rat brain development |
| 155.13 | The modulation of calcium currents by | D2 and opioid agonists in rat globus pallidus following dopamine denervatio |
| 013.8 | D2 dopamine receptor activation decreases rapidly inactivating and persiste | |
| 056.4 | Selective stimulation of striatal D1 or | D2 dopamine receptors causes opposite changes on fos expression in the rat |
| 153.4 | Involvement of D1 and | D2 dopaminergic receptors in cocaine-seeking behaviour reinstatement: effec |
| 012.4 | Inverse agonist properties of dopamine | D2 receptor antagonists using [35S]GTPgammaS binding responses on digitonin |
| 180.2 | Localization of D1 and | D2 receptors and dopamine receptor interacting proteins in the prefrontal c |
| 012.22 | Presence of dopamine D1 and | D2 receptors subtypes in the mammal ependyma |
| 047.5 | Inhibition of dopamine release via presynaptic | D2 receptors: time course and functional characteristics in vivo |
| 115.6 | Developmental changes in calcium channel subtypes and | D2-like receptor-mediated presynaptic inhibition in GABAergic transmission |
| 012.11 | Dopamine | D2/D3 receptor mediated modulation of cerebellar spike activity |
| 224.6 | 1, 25-Dihydroxyvitamin | D3 (1, 25-D3) and 17beta-estradiol (E) reduce infarct size and heme oxygena |
| 175.7 | Modifications induced by 7-OH-DPAT, a | D3 dopamine receptor agonist, on orienting motor response, in the rat |
| 056.14 | Characterisation of a tau-LacZ | D3 dopamine receptor mutant mouse in adulthood and embryonic development |
| 042.11 | Isolation rearing reduces the expression of a dopamine | D3 mediated behavioral response in the rat |
| 042.7 | The dopamine | D3 receptor (D3-R) partial agonist, BP-897, reduces the acquisition and the |
| 091.3 | s accumbens neurons projecting to mesencephalon express dopamine | D3 receptor in rat brain |
| 122.10 | mipramine and amantadine on binding of [3H]7-OH-DPAT to dopamine | D3 receptors in peripheral blood lymphocytes of drug-resistant depressed pa |
| 213.11 | atment with imipramine and amantadine on central dopamine D2 and | D3 receptors in rats |
| 057.17 | PD 128907, a | D3 selective agonist, and behavioral sequence associated with satiety, in t |
| 012.23 | D4 and D1/D5 dopamine receptors interact synergistically on c-Fos expressio | |
| 178.14 | Potentially functional difference between dopamine | D4 receptor variants |
| 012.15 | Expression of dopamine receptor D2 and | D4 subtypes during postnatal rat brain development |
| 037.3 | Regulation of dopamine | D5 receptor expression by BDNF in mouse striatal astrocytes during developm |
| 210.5 | Effects of lever pressing and expected rewards on dopamine ( | DA) and noradrenaline (NA) efflux measured by microdialysis in the prefront |
| 175.3 | Hyperactivity induced by subconvulsive NM | DA stimulation of the rat ventral hippocampus: post mortem neurochemistry d |
| 056.10 | Influence of the circadian rhythm and of dopamine ( | DA) on the inhibitory mu-opiate receptor regulation of the NMDA-evoked rele |
| 205.9 | Dab1 mRNA and protein expression in developing human cortex | |
| 220.14 | Delayed auditory feedback ( | DAF) leads to a reduction in modulation frequency of isolation calls in juv |
| 182.14 | Detection of oxidative stress in glial cultures: | DAF-2 fluorescence used as a tool to measure peroxynitrite rather than nitr |
| 226.7 | emergence of behavioral changes after neonatal excitotoxic brain | damage |
| 054.6 | erisation of nitrated astrocytes following postnatal excitotoxic | damage |
| 050.9 | Glial cell plasticity in sensory ganglia induced by nerve | damage |
| 224.28 | ATP-regulated K+-channel opening affects ischemia-induced | damage and long-term potentiation in rat hippocampus in vitro |
| 187.18 | Oxidative stress and neuronal | damage during experimental status epilepticus in hippocampal slice cultures |
| 189.4 | Early markers of brain | damage in a rat model of hypoxic/ischemic encephalopathy: alterations in ne |
| 224.31 | Angiopoietin-1 counteracts VEGF-induced | damage in the ischemic brain |
| 121.2 | ng, and their cellular correlates, of status epilepticus-induced | damage in the rat cerebral cortex, hippocampus, amygdala and thalamus |
| 072.5 | ammatory molecules by Triflusal post-treatment after excitotoxic | damage to the postnatal brain |
| 174.29 | Properties of place cell firing after | damage to the visual cortex |
| 073.6 | Maternal chronic ultra mild stress increases neonatal brain | damage vulnerability in c57bl/6 mice |
| 224.29 | Synaptic NMDA receptors and hypoxic | damage: role of adenosine |
| 108.10 | show faster saccadic latency to ipsilesional targets than brain- | damaged and healthy controls |
| 208.16 | The role of Oct6 in the | damaged and regenerating brain: an in vitro approach |
| 208.5 | Gp130 cytokines determine the growth status of | damaged sensory axons within the CNS |
| 087.8 | A transgenic model to monitor neuronal | damages |
| 178.2 | D-Ala2, N-MePhe4, Gly5-ol-enkephalin ( | DAMGO), a mu-opioid receptor agonist, selectively inhibits a subset of neoc |
| 226.28 | Dantrolene partially prevents excitotoxicity-induced mitochondrial permeabi | |
| 155.16 | Role of D1 dopamine receptor ( | DAR) in controlling the flow of cortical activity through the striatal medi |
| 017.4 | ldfish, zebrafish and cichlid fish retinae: effects of light and | dark adaptation and relation to double cones |
| 042.1 | n exposure to an open field, the elevated plus maze or the light- | dark shuttle box |
| 017.2 | Characterisation of the mouse " | dark-flash" electroretinogram (ERG) |
| 053.1 | the level of cAMP formation and at the phosphorylation state of | DARPP-32 in the striatum of the "weaver" mouse: a genetic model of Parkinso |
| 174.17 | Behavioural lateralization in dopamine-transporter ( | DAT) knockout mice |
| 245.2 | NEUROGENERATOR - A | database generator for human brain imaging |
| 212.5 | SCID: a relational | database system for mental health clinical research |
| 245.1 | Non-curated distributed | databases for experimental data and models in neuroscience |
| 106.13 | ions on cognitive performance in inbred mice strains C57BL/6 and | DBA/2 |
| 073.17 | Neonatal thyroxine treatment of | DBA/2J male mice induces developmental and behavioural changes in their F1 |
| 082.17 | ferences in hippocampal synaptic plasticity between C57BL/6J and | DBA/2J mice: Implications for learning and memory |
| 089.3 | Effect of | dbAMPc on expression of dystrophin isoforms, utrophin and beta-dystroglycan |
| 187.3 | Effects of uniform | DC electrical fields on hippocampal function in-vitro |
| 224.15 | educed the size of ischaemic infarcts, but did not alter EEG and | DC-potential changes associated with transient global ischaemia |
| 146.7 | t clamp study of synaptic integration in deep cerebellar nuclei ( | DCN) neurons: comparing the roles of AMPA-NMDA and GABA-A inputs |
| 209.6 | Correlations between Down chromosomal region ( | DCR) and behavioral and neuronal characteristics in polytransgenic mice |
| 190.8 | ion of cortical GAD67 and reelin in mice is inhibited by histone | deacetylase inhibitors |
| 209.10 | urized, electronically controlled, cooling device for reversible | deactivation of the rat hippocampus |
| 029.1 | of the auditory cortex to cochlear implantation in congenitally | deaf cat |
| 220.8 | Effects of unilateral | deafening on contralateral cochlear active mechanisms in young guinea pigs |
| 185.18 | Peripheral | deafferentation modulates the distribution of protein kinase A regulatory s |
| 092.1 | Modifications of the intrinsic membrane properties of | deafferented vestibular neurones one month after unilateral labyrinthectomy |
| 219.2 | ulation of GABA-A and GABA-B receptors and of their mRNAs in the | deafferented vestibular nuclei and the axotomized facial nucleus after unil |
| 220.16 | KCNQ channel blockade causes OHC degeneration and | deafness in the mammalian cochlea |
| 098.1 | Human hereditary | deafness: from genes to inner ear physiology |
| 105.2 | xpression of RORalpha protects cortical neurons against neuronal | death |
| 053.11 | Protective effect of Parkin against ceramide-mediated cell | death |
| 052.14 | xonal abnormalities and severe neuronal dysfunction without cell | death |
| 226.26 | increases neuronal cell survival in a model of progressive cell | death |
| 019.9 | del of polyglutamine-dependent neuronal dysfunction without cell | death |
| 058.15 | to glutamate excitotoxicity, resulting in progressive motoneuron | death |
| 222.6 | e of DNA polymerases expression in beta-amyloyd-induced neuronal | death |
| 177.6 | el to study the mechanisms of nitric oxide induced neuronal cell | death |
| 152.7 | -linked SOD1 mutations show increased sensitivity to Fas-induced | death |
| 184.5 | gap junction network causes hearing impairment and massive cell | death |
| 149.18 | lvement of caspases in the beta-amyloid peptide-induced neuronal | death |
| 222.3 | role of calcineurin on amyloid beta 25-35 induced apoptotic cell | death |
| 137.8 | Learning in rats induces cell | death and cell proliferation in the adult hippocampus |
| 150.16 | n a cell- and time dependent manner in association with neuronal | death and glial reactivity after global forebrain ischemia |
| 149.2 | and neurotrophic support confers partial protection against cell | death and loss of metabolic activity of a catecholaminergic cell line (CAD) |
| 223.23 | Neuronal | death and mossy fibers sprouting are reduced in TIMP-1 deficient mice after |
| 088.17 | Dexamethasone induced changes in cell | death and proliferation in the adult human hippocampus |
| 105.8 | Cell proliferation, | death and survival in the developing cerebellar cortex of cisplatin treated |
| 149.19 | llar granule cells neither from glutamate toxicity nor apoptotic | death by potassium deprivation |
| 148.3 | IL-1beta exacerbates excitotoxin induced neuronal cell | death by potentiating seizure activity |
| 037.8 | Dopaminergic neuronal | death caused by glial cells is prevented by cyclic AMP through a mechanism |
| 105.16 | Initiation of motoneuron developmental | death depends on macrophage-derived TNFalpha |
| 080.7 | a2+ channels in human neuroblastoma IMR32 cell proliferation and | death following extremely low frequency (ELF) magnetic field (MF) stimulati |
| 150.12 | Relation between extent of cell | death in CA1 and electrophysiological function in dentate gyrus after globa |
| 044.4 | Protective effects of steroids against glutamate-induced cell | death in cerebellar granule neurons |
| 120.17 | Abnormal synaptic protein expression and cell | death in murine scrapie |
| 222.11 | NGF protects cholinergic neurons against TNF-alpha induced cell | death in organotypic brain slices |
| 015.1 | Lack of PSD-95 drives hippocampal neuronal | death in organotypic slices |
| 032.3 | Neuronal | death in prion disease |
| 226.24 | Increased cell | death in selenium deficient rats following glutamate-induced excitotoxicity |
| 087.7 | ression of microglia and astrocytes during dopaminergic neuronal | death in the weaver mice |
| 054.20 | ect cultured spinal cord motoneurons from excitotoxicity-induced | death in vitro |
| 191.13 | Involvement of mitochondrial apoptotic pathway in PC12 cell | death induced by heroin, amphetamine and cocaine |
| 151.2 | Citicoline reduces caspase-3 activation and cell | death induced by staurosporine in SH-SY5Y human neuroblastoma cells |
| 148.17 | Cell | death inhibition by full length survival motor neuron (smn) protein |
| 105.17 | Molecular characterisation of caspase-independent cell | death of cerebellar granule neurons |
| 007.12 | Comparison of cell | death pattern during development of avian and reptilian visual systems |
| 149.28 | Quantitation of cell | death rate in developing rat brain - a comparison of histological methods f |
| 120.23 | brane fragment of the human prion protein induces apoptotic cell | death to primary rat oligodendrocytes : involvement of oxidative stress |
| 186.12 | 6-hydroxydopamine-induced cell | death: involvement of oxidative stress and apoptosis |
| 056.1 | Inhibition of dopa | decarboxylase enhances the locomotor response to L-dopa in reserpine-treate |
| 084.20 | Levodopa improves lexical | decision accuracy in subjects with anhedonics traits |
| 009.1 | Role of the orbitofrontal and anterior cingulate cortex in | Decision-making in the conditioned Monkey |
| 174.2 | Procedural memory and | declarative memory are stored independently in terrestrial snail |
| 008.5 | lysis, development of a direct animal analogue of this human non- | declarative memory task, and contributions of both human and animal SRT tas |
| 151.10 | sease: the influence of apolipoprotein on pathological cognitive | decline |
| 008.1 | Functional neuroanatomy of age-related episodic memory | decline using PET subtraction and correlation methods |
| 096.1 | Modelling the cerebellum as a | decorrelation controller |
| 142.9 | Assessing a vigilance | decrement in the 5-choice serial reaction time task: Effect of age, pre-fee |
| 105.4 | The | ded-containing protein pea-15 inhibits erk/mapk nuclear signaling by enforc |
| 145.11 | bout the important role of NO in the mechanisms of mitochondrial | deenergization and glutamate neurotoxicity |
| 041.20 | Deep-to-superficial layer communication in the rat entorhinal cortex | |
| 154.3 | nin receptor agonist S23478 in a model of anticipation of social | defeat in the rat: effects on cortical CCK release |
| 083.9 | Recovery of chronic homonymous post-stroke visual field | defect after computer-assisted training detected by visual perimetry and vi |
| 003.15 | n of Gcm1 during murine embryogenesis induces severe neurulation | defects |
| 147.2 | ssion of brain cold-stable microtubules in mice induces synaptic | defects associated with neuroleptic-sensitive behavioral disorders |
| 124.6 | Brain cortex plasticity at the visual and acoustic systems | defects compensation |
| 152.5 | Genetic screening of an experimental model of ALS reveals early | defects in intermediary metabolism |
| 207.4 | Defects in motoneuron sub-populations in the reeler mutant mouse | |
| 155.11 | structure and reverses the dopamine denervation-induced cellular | defects in the output structures of the basal ganglia in the rat |
| 149.14 | Neuronal | defense against cisplatin mediated by extracellular signal regulated kinase |
| 123.3 | Inhibition of the baroreflex bradycardia during | defense reaction involves 5-HT3 receptors in the nucleus tractus solitarius |
| 123.21 | Arousal and | defensive reactions in mice selected for post-stress analgesia |
| 173.2 | n the rat brain and its alteration following lesion and selenium | deficiency |
| 082.3 | Functional consequences of the | deficiency in extracellular matrix proteoglycans brevican and neurocan in t |
| 046.14 | Parvalbumin | deficiency induces changes in Purkinje cell morphology: compensation mechan |
| 010.2 | t of a chronic (n-3) polyunsaturated fatty acids (PUFAs) dietary | deficiency on cholinergic neurotransmission in rat brain |
| 172.17 | Reversibility of n-3 polyunsaturated fatty acid diet | deficiency-induced alterations of dopaminergic neurotransmission: critical |
| 057.12 | Neuroendocrine regulation in mice | deficient for multidrug-resistance gene 1-type P-glycoproteins |
| 176.13 | Behavioral properties of mice | deficient in AMPA-type glutamate receptors GluR-A subunit: aggression, anxi |
| 157.14 | hanges in glucose transport and utilization in the brain of rats | deficient in n-3 polyunsaturated fatty acids |
| 122.4 | endent desensitization of 5-HT1A autoreceptors in knock-out mice | deficient in the 5-HT transporter |
| 087.1 | n organic cation transporter expression in serotonin transporter | deficient mice |
| 004.14 | Inner ear efferences are affected in Mash1 | deficient mice |
| 010.5 | ntracytoplasmic stores in neurons of acetylcholinesterase (AChE) | deficient mice |
| 223.23 | Neuronal death and mossy fibers sprouting are reduced in TIMP-1 | deficient mice after excitotoxic seizures |
| 223.24 | Adenosine A2A receptor | deficient mice are more resistant to seizures |
| 141.11 | Behavior analysis of RSK2 | deficient mice: An animal model for the cognitive impairment In the Coffin- |
| 172.24 | Normal development of thalamocortical projections in the SNAP-25 | deficient mouse |
| 015.5 | Formation of glutamatergic synapses in N-cadherin | deficient mouse embryonic stem cells after neuronal differentiation in vitr |
| 141.12 | ebroventricular NGF infusions on spatial memory in adult, memory | deficient rats |
| 226.24 | Increased cell death in selenium | deficient rats following glutamate-induced excitotoxicity |
| 168.3 | thanol leads to a post-pubertal emergence of a latent inhibition | deficit accompanied by altered morphology in limbic and paralimbic cortical |
| 175.22 | ed with enriched-environment housing attenuates spatial learning | deficit after focal cerebral ischemia in rats |
| 189.1 | ne and serotonin disbalance in a novel mouse model for attention | deficit and hyperactivity disorder (ADHD) |
| 009.5 | el of Tourette's syndrome: Induction of hyperactivity, attention | deficit and stereotypy by microinjections of Bicuculline in the external se |
| 075.9 | gnetic fields in rats: changes in Fos protein expression without | deficit in cognitive performance |
| 008.4 | Neural substrates of episodic memory | deficit in mild cognitive impairment (MCI) using voxel-based-morphometry (V |
| 209.16 | GFRalpha2 knockout mice exhibit | deficit in place navigation in water a maze |
| 142.12 | A | deficit in visual acuity in plasminogen activator inhibitor-1 knockout (PAI |
| 084.17 | Top down control | deficit in visuospatial context processing relationship with fronto hippoca |
| 084.9 | An animal model with relevance to the glutathione | deficit observed in schizophrenia |
| 141.5 | Exogenous high corticosterone abolished behavioural | deficit of apolipoprotein E knockout mice as assessed by the water maze tas |
| 126.3 | p53 knock-out mice display a | deficit of motor synchronization, likely due to absence of p53 gene in adul |
| 213.3 | Reboxetine antagonizes the avoidance | deficit produced by acute or chronic exposure to unavoidable stress in rats |
| 087.2 | usly hypertensive rat (SHR) strain, an animal model of attention | deficit with hyperactivity disorder (ADHD) |
| 124.28 | Visual target selection | deficits after parietal inactivation in monkey |
| 227.5 | Analysis of hindlimb locomotor | deficits after partial spinal lesion in rats |
| 055.9 | Correlations between cognitive | deficits and brain pathology in the Alzheimer model PD-APP transgenic mice |
| 041.31 | Learning | deficits and dysfunctional synaptic plasticity induced by aggregated amyloi |
| 091.13 | Spontaneous motor behavioural | deficits and increased striatal sensitivity to 3-nitropropionic acid in dop |
| 224.5 | gly-pro ("Semax") and glycine on the development of neurological | deficits and nitric oxide generation in rats with incomplete global ischemi |
| 075.5 | Modelling cognitive | deficits associated with Alzheimer's disease |
| 134.2 | Prenatal stress produces learning | deficits associated with an inhibition of neurogenesis in the hippocampus |
| 151.20 | Mice over-expressing human caspase-3 exhibit cognitive | deficits in an olfactory working memory task |
| 040.3 | Specific learning and memory | deficits in Balb/c mice with bilateral dorsal or ventral hippocampal lesion |
| 141.1 | Spatial learning and memory | deficits in LHX-7 genetically modified mice |
| 057.15 | Alimentary tract | deficits in mice lacking GDNF-family receptor alpha2 |
| 084.8 | in the prefrontal cortex of rats with isolation rearing-induced | deficits in prepulse inhibition of acoustic startle |
| 174.24 | Isolation rearing of rats produces | deficits in prepulse inhibition of acoustic startle response, but does not |
| 085.6 | t not compensate for the aging-related spatial and monoaminergic | deficits in rats |
| 138.8 | orphological alterations of the cerebellar cortex and functional | deficits occur in transgenic mice misexpressing the axonal glycoprotein F3/ |
| 115.17 | Targeted disruption of the mouse bassoon gene results in | deficits of presynaptic function |
| 227.10 | ays offer improved sensitivity for measuring motor co-ordination | deficits over the mouse rotarod |
| 072.13 | Genetic ablation of TGF-beta1 results in accumulation of | degenerating neurons and increased neuronal susceptibility to injury in mic |
| 054.14 | Early upregulation of Alix in brain areas of kainate-induced | degeneration |
| 148.6 | Metallothionein protects the CNS during neuroglial | degeneration |
| 020.10 | ein kinase (PKR) is implicated in beta-amyloid toxicity and neuro | degeneration |
| 225.10 | Peripheral nerve | degeneration / regeneration in nNOS knockout mice |
| 225.1 | Nmnat chimeric gene (WldS) protects injured axons from Wallerian | degeneration and alleviates some neurodegenerative diseases |
| 220.16 | KCNQ channel blockade causes OHC | degeneration and deafness in the mammalian cochlea |
| 152.9 | Necrosis, apoptotic like | degeneration and motor neurone loss following passive transfer of IgG from |
| 224.24 | Role of ERK1/2 activation in neuro | degeneration and neuroprotection in in vitro models of excitotoxic and isch |
| 241.1 | Molecular events in neuro | degeneration and Parkinsonism: studies from cDNA microarrays |
| 117.12 | erks, jnks, p38) in the olfactory epithelium during the neuronal | degeneration and regeneration processes induced by removal of the olfactory |
| 222.9 | plement C5a receptor mediated signalling may be involved in neuro | degeneration in Alzheimer's disease |
| 226.2 | production in the neuronal cell line rcsn-3: cell model to neuro | degeneration in parkinson's disease |
| 091.4 | na muricata (Annonaceae) induces basal ganglia and mesencephalon | degeneration in rats |
| 054.1 | ate receptor and metabotropic receptor 6 following photoreceptor | degeneration in RCS rat retina |
| 139.6 | ceptor antagonist, dexefaroxan, against basocortical cholinergic | degeneration in the adult rat may involve upregulation of nerve growth fact |
| 187.4 | Overkindling-induced neuro | degeneration in the hilus is not associated with the occurrence of spontane |
| 054.3 | Striatal | degeneration induced by chronic energy compromise is associated with a calp |
| 139.11 | neurons of substantia nigra pars compacta against transneuronal | degeneration induced by striatal excitotoxicity |
| 242.4 | Parkinson-like neuro | degeneration induced by targeted overexpression of alpha-synuclein in the n |
| 226.6 | he differential involvement of caspase 3 and calpain in striatal | degeneration induced by the mitochondrial toxin 3-nitropropionic acid |
| 011.2 | Photoreceptor | degeneration induced by Vigabatrin, an antiepileptic drug |
| 225.2 | The slow Wallerian | degeneration mutation (wlds) : genotyping methods and mutation stability st |
| 226.28 | otoxicity-induced mitochondrial permeability transition and neuro | degeneration of cultured cerebellar granule cells: relevance to glutamate a |
| 091.17 | plex I with rotenone induces a hypokinetic syndrome in rats with | degeneration of multiple neuronal systems |
| 126.10 | Hindlimb paresis and selective | degeneration of the inferior olive neurons in rats exposed to trans-crotono |
| 226.4 | al syndrome caused by allylnitrile in the rat is associated with | degeneration of the vestibular sensory hair cells |
| 091.1 | Effects of thalamic | degeneration on gene expression in the basal ganglia in a rat model of Park |
| 054.11 | mitochondrial toxin, 3-nitropropionic acid induces striatal neuro | degeneration via a c-jun n-terminal kinase/c-jun module |
| 085.12 | Aging does not induce prominent cell loss but fiber | degeneration within the amygdala and hippocampus |
| 091.10 | ic system in an animal model of cerebellar ataxia (Purkinje cell | degeneration) |
| 186.17 | inesias in a rat model of multiple system atrophy (striatonigral | degeneration) |
| 032.2 | The biology of glutamate transporters and their role in neuro | degeneration, stem cell pathogenesis and neurological disorders |
| 195.1 | ubtype-selective metabotropic glutamate receptor ligands in neuro | degeneration/neuroprotection |
| 188.11 | Autoimmune vaccine therapy for CNS | degeneration: Post-traumatic vaccination with myelin promotes recovery from |
| 171.15 | ession correlates with a persistent glial activation in the neuro | degenerative cerebellum of the Lurcher mutant mice |
| 186.13 | Temporal pattern of behavioural and | degenerative changes in nigral dopaminergic neurons in an early model of Pa |
| 242.1 | Lentiviral vectors as gene delivery system for neuro | degenerative diseases |
| 225.1 | jured axons from Wallerian degeneration and alleviates some neuro | degenerative diseases |
| 053.2 | on of the immunophilin fkbp12 in the brain of patients with neuro | degenerative diseases |
| 241.3 | Gene chips for analysis of expression changes in neuro | degenerative diseases such as stroke |
| 019.13 | Behavioural and neuro | degenerative phenotypes are induced after expression of polyglutamine-expan |
| 124.23 | Degradation of chondroitin-sulfate proteoglycans (CSPGs) restores ocular do | |
| 020.6 | Degradation of rat hippocampal APP is associated with increased LRP express | |
| 019.12 | Proteasome | degradation of soluble expanded polyglutamine |
| 143.8 | itive step in the muscle nicotinic acetylcholine receptor (AChR) | degradation pathway |
| 223.2 | C6 glioma cells: potential involvement of the phosphodiesterase | degradation system |
| 010.3 | Oligomerisation of acetylcholinesterase T blocks its | degradation via the ubiquitin-proteasome pathway, by masking the C-terminal |
| 086.12 | Long lasting antinociceptive properties of the enkephalin | degrading enzyme inhibitor prodrug, RB 3007 in various pharmacological test |
| 089.7 | Dystrophins and utrophin distribution in normal and | dehydrated rat neurohypophysis |
| 057.9 | Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of | |
| 211.13 | The importance of | dehydroepiandrosterone in memory consolidation in the day-old chick |
| 119.18 | Suppression of astroglial pyruvate | dehydrogenase E1 mRNA expression during hibernation-induced reduction of gl |
| 224.8 | Protective effect of pirlindole and | dehydropirlindole, two monoamine oxidase type A (MAO-A) inhibitors, against |
| 210.7 | The involvement of the anterior cingulate cortex in trace versus | delay fear conditioning demonstrated by lesion and c-fos mRNA in situ hybri |
| 210.11 | Selective attentional modulation of trace vs. | delay fear conditioning in C57BL/6N mice |
| 104.1 | ngrailed-2 overexpression in cerebellar Purkinje cells induces a | delay in Purkinje cell differentiation and a downregulation of tetraspanin- |
| 009.17 | al cortex is also involved in preparation of action : the double | delay tasks |
| 107.20 | Blockade of dopamine D1/D5 receptors causes a | delay-dependent impairment of spatial memory in a watermaze matching-to-pla |
| 043.3 | fects of neonatal lesions of the rat medial prefrontal cortex on | delayed alternation performance and sensorimotor gating |
| 220.14 | Delayed auditory feedback (DAF) leads to a reduction in modulation frequenc | |
| 153.1 | Chronic exposure to benzodiazepine agonists produces a | delayed but transient increase in fosB gene products in rat striatum |
| 142.8 | sulphate into the pedunculo-pontine tegmental nucleus induces a | delayed increase of paradoxical sleep in the rat |
| 179.8 | Differential effects of PTZ on the transient and | delayed rectifier outward K+ currents in F1 neuronal soma membrane of Helix |
| 179.19 | Enhancement of | delayed-rectifier K+ current by local anesthetics in spinal sensory neurons |
| 211.11 | Arginin aspartate (Dynamisan forte) improves spatial memory and | delays simple reactions in humans |
| 019.11 | Increasing the degree of environmental enrichment further | delays the onset of key symptoms in Huntington's disease in mice |
| 141.2 | Mice with a brain-specific c-fos | deletion are impaired in hippocampus-dependent learning and synaptic plasti |
| 042.15 | iation of effects of stimuli conditioned to appetitive events by | deletion of glutamate receptor GluR1 subunit |
| 150.4 | Gene | deletion of IL-1 receptor type I accessory protein does not affect infarct |
| 053.27 | on of a subpopulation of the inbred mouse strain C57BL/6J with a | deletion of the alpha-synuclein locus and evaluation of spatial learning in |
| 072.8 | Deletion of the CXC chemokine receptor-4 impairs the development of the per | |
| 065.2 | Targeted gene | deletion to study the involvement of dopamine receptors in the response to |
| 138.16 | Deletions in GAP-43 sequence differentially affect filopodia induction. Is | |
| 057.13 | ygdala of transgenic mice is modulated during pregnancy or after | delivery |
| 115.2 | Cell-penetrating peptide transportan in cellular cargo | delivery |
| 010.5 | face acetylcholine (ACh) muscarinic receptors m2R due to limited | delivery from intracytoplasmic stores in neurons of acetylcholinesterase (A |
| 146.26 | Potential utility of reverse microdialysis for discrete | delivery of antisense molecules in the CNS |
| 171.3 | Cell-based | delivery of appropriate cytokines allows for the differentiation of a doxyc |
| 155.19 | Lentiviral-mediated | delivery of ciliary neurotrophic factor protects striatal neurones in a tra |
| 018.21 | Delivery of sonic hedgehog and glial derived neurotrophic factor to dopamin | |
| 229.8 | Effects of NT-4 | delivery on reinnervation of fast extensor digitorum longus (EDL) and slow |
| 242.1 | Lentiviral vectors as gene | delivery system for neurodegenerative diseases |
| 148.5 | In vivo gene | delivery to the cns using a novel integrin targeting multifunctional protei |
| 145.10 | interacting with the neuronal calcium sensor protein neurocalcin | delta |
| 081.11 | hannel properties and pore-blocking drugs that glutamate channel | delta 2 underlies the metabotropic slow EPSP in cerebellar Purkinje neurone |
| 211.7 | Differential effects of CB1 receptor agonists WIN 55, 212-2 and | Delta 9-THC and the anxiolytic diazepam in a novel place preference task |
| 040.11 | Delta catenin, a presenilin-1-interacting adhesion molecule in neuronal syn | |
| 138.13 | Mu and | delta opioid receptor distribution and regulation in cultured cells from la |
| 056.3 | Striatal modulation of glutamate release by | delta opioid receptors and its consequences on dopamine release |
| 076.4 | Differential effects of mu-, | delta-, and kappa-opioid receptor agonists on nociception in the cyclophosp |
| 142.13 | Do | delta-9-tetrahydrocannabinol chronic treatment lead to behavioural sensitiz |
| 073.14 | ion and neuroendocrine activity in the adulthood after perinatal | delta-9-tetrahydrocannabinol exposure |
| 112.15 | Delta-9-THC pretreatment of adult rats does not increase morphine self-admi | |
| 151.15 | Aberrant phosphorylation and inactivation of | delta-CaM kinase II in fibroblasts from Alzheimer's disease patients |
| 183.11 | tial descending control from the periaqueductal grey of C- and A | delta-nociceptive responsiveness is not exerted on lamina V neurones that r |
| 183.11 | n lamina V neurones that receive convergent inputs from C- and A | delta-nociceptors |
| 191.6 | nto the ventral tegmental area of mice lacking either the mu- or | delta-opioid receptor genes |
| 178.11 | Differential sorting of human | delta-opioid receptors after internalization by peptide and alkaloid agonis |
| 178.8 | Desensitization of human | delta-opioid receptors by enkephalins and SNC 80 |
| 142.4 | ovian degraded contingency preparation in rats: implications for | delusion disorders in humans |
| 222.16 | ve mediotemporal pathology within the spectrum of frontotemporal | dementia |
| 241.2 | e-chip technology to study differential gene expression in human | dementia |
| 222.1 | icity of antipsychotic drugs in Alzheimer's disease and vascular | dementia |
| 186.10 | ptor subunits in the temporal cortex in Parkinson's disease with | dementia and controls |
| 151.21 | Soluble amyloid beta-protein is increased in frontotemporal | dementia associated with tau gene mutations |
| 084.2 | Psychiatric manifestations and early onset | dementia in adult neurolipidoses |
| 020.27 | Treatment of | dementia: ADAM10 in Alzheimer disease patients |
| 221.4 | Gene transfer in the | demyelinated adult spinal cord using AAV-transduced primate Schwann cells |
| 221.8 | Visual evoked potentials in | demyelinating diseases |
| 221.5 | RPTP-beta is involved in functional recovery from | demyelinating lesion of the spinal cord |
| 050.26 | Mechanisms of neuropathic pain in peripheral | demyelination |
| 221.3 | Lipopolysaccharide-induced central | demyelination : the effect of treatment with the steroidal anti-inflammator |
| 192.4 | ailing expression of HSP70 in oligodendrocytes following protein | denaturation stress in vivo could be a cell survival factor |
| 185.1 | Olfaction in heliothine moths: IV. Coding properties and | dendrite arborizations in identified glomeruli of antennal lobe output neur |
| 138.19 | Semaphorin 3A regulates cortical axon and | dendrite matrix metalloprotease (MMP) - dependent outgrowth |
| 223.25 | rent excitation induces action potential initiation in the basal | dendrite of CA1 neurons in the ventral hippocampus |
| 012.16 | ng mediates plasma membrane recovery of dopamine D1 receptors in | dendrites and axons after agonist-induced endocytosis in primary cultures o |
| 081.10 | Ca2+ dynamics in | dendrites and spines in layer 4 spiny stellate cells of the juvenile rat so |
| 141.10 | Parvalbumin immunoreactive | dendrites co-localize with apical dendritic bundles of layer 2 pyramidal ne |
| 147.5 | Translocation of nuclear SAM68 to | dendrites in depolarized hippocampal neurons : implication in RNA transport |
| 015.12 | amatergic synapses between inner hair cells and auditory neurons | dendrites in the rat cochlea: upregulation of presynaptic proteins and chan |
| 015.16 | Ca2+ signaling in small oblique | dendrites of CA1 pyramidal neurons |
| 121.1 | A novel population of calretinin-positive neurons innervates | dendrites of calbindin negative granule cells in the molecular layer of the |
| 095.3 | w signal for coincidence detection: Na+ transients in spines and | dendrites of hippocampal neurons |
| 052.21 | Action potentials in distal apical | dendrites of layer 2/3 neocortical pyramidal neurones studied both in vitro |
| 046.12 | 5-HT-mediated regulation of GABA output from | dendrites of local thalamic interneurons |
| 229.4 | Localization of the Vps10p domain receptor SorCS1 in somata and | dendrites of neurons throughout the murine brain |